Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/8/2088/13789582/mdt140.pdf
Reference17 articles.
1. A meta-analysis of thoracic radiotherapy for small-cell lung cancer;Pignon;N Engl J Med,1992
2. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group;Murray;J Clin Oncol,1993
3. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study;Jeremic;J Clin Oncol,1997
4. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group;Work;J Clin Oncol,1997
5. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083;Perry;J Clin Oncol,1998
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Dose/Fractionation Debate in Limited-Stage Small Cell Lung Cancer;Cancers;2024-05-17
2. Six versus four or five cycles of first‐line etoposide and platinum‐based chemotherapy combined with thoracic radiotherapy in patients with limited‐stage small‐cell lung cancer: A propensity score‐matched analysis of a prospective randomized trial;Cancer Medicine;2024-04
3. Thoracic radiotherapy timing and prognostic factors in elderly patients with limited‐stage small cell lung cancer;Precision Radiation Oncology;2024-03
4. Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer;Radiation Oncology Journal;2023-12-31
5. Coronavirus disease 2019 and lung cancer: where are we?;Exploration of Targeted Anti-tumor Therapy;2023-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3